MucositisRadiotherapyStomatitisAntineoplastic Combined Chemotherapy ProtocolsRadiotherapy DosageRadiotherapy, AdjuvantCombined Modality TherapyChemotherapy, AdjuvantRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedTreatment OutcomeRadiation InjuriesRadiotherapy Planning, Computer-AssistedRadiotherapy, High-EnergyCisplatinMouth MucosaAntineoplastic AgentsDose FractionationDisease-Free SurvivalHead and Neck NeoplasmsNeoplasm StagingCyclophosphamideDoxorubicinSurvival AnalysisNeoplasm Recurrence, LocalSurvival RateRadiotherapy, Computer-AssistedRadiotherapy, Image-GuidedNeoadjuvant TherapyBreast NeoplasmsLung NeoplasmsDrug Administration SchedulePrognosisEtoposideMethotrexateNeoplasmsChemoradiotherapyCarcinoma, Squamous CellAntimetabolites, AntineoplasticFollow-Up StudiesRadiation OncologyCarboplatinBrain NeoplasmsNasopharyngeal NeoplasmsFluorouracilVinblastineDose-Response Relationship, RadiationPaclitaxelBleomycinCranial IrradiationBrachytherapyTaxoidsRadiosurgeryAntineoplastic Agents, AlkylatingSalvage TherapyIfosfamideHodgkin DiseaseTime FactorsCarcinoma, Non-Small-Cell LungDeoxycytidineXerostomiaAdenocarcinomaNeoplasm MetastasisNeutropeniaProspective StudiesDacarbazineInduction ChemotherapyRadiodermatitisRadiation-Sensitizing AgentsRectal NeoplasmsKaplan-Meier EstimateOrganoplatinum CompoundsTransplantation, AutologousRadiation ToleranceInfusions, IntravenousThiotepaLymphoma, Non-HodgkinRetrospective StudiesCarcinomaLeukopeniaAmifostinePalliative CareDrug Resistance, NeoplasmRadiation-Protective AgentsBone NeoplasmsOrgans at RiskAntineoplastic Agents, PhytogenicCytarabineFeasibility StudiesNeoplasms, Second PrimaryHematopoietic Stem Cell TransplantationDose-Response Relationship, DrugTesticular NeoplasmsTomography, X-Ray ComputedLomustineMelphalanLymphatic MetastasisProstatic NeoplasmsNauseaClinical Trials as Topic